AUTHOR=Marco Eva M., García-Gutiérrez María S. , Bermúdez-Silva Francisco-Javier , Moreira Fabricio , Guimarães Francisco , Manzanares Jorge , Viveros Maria-Paz TITLE=Endocannabinoid System and Psychiatry: In Search of a Neurobiological Basis for Detrimental and Potential Therapeutic Effects JOURNAL=Frontiers in Behavioral Neuroscience VOLUME=5 YEAR=2011 URL=https://www.frontiersin.org/journals/behavioral-neuroscience/articles/10.3389/fnbeh.2011.00063 DOI=10.3389/fnbeh.2011.00063 ISSN=1662-5153 ABSTRACT=
Public concern on mental health has noticeably increased given the high prevalence of neuropsychiatric disorders. Cognition and emotionality are the most affected functions in neuropsychiatric disorders, i.e., anxiety disorders, depression, and schizophrenia. In this review, most relevant literature on the role of the endocannabinoid (eCB) system in neuropsychiatric disorders will be presented. Evidence from clinical and animal studies is provided for the participation of CB1 and CB2 receptors (CB1R and CB2R) in the above mentioned neuropsychiatric disorders. CBRs are crucial in some of the emotional and cognitive impairments reported, although more research is required to understand the specific role of the eCB system in neuropsychiatric disorders. Cannabidiol (CBD), the main non-psychotropic component of the